166 related articles for article (PubMed ID: 32950451)
1. Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis.
Slivnick JA; Tong MS; Nagaraja HN; Elamin MB; Wallner A; O'Brien A; Raman SV; Zareba KM
JACC Cardiovasc Imaging; 2021 Jan; 14(1):302-304. PubMed ID: 32950451
[No Abstract] [Full Text] [Related]
2. CMR and amyloid cardiomyopathy: are we getting closer to the biology?
Kwong RY; Jerosch-Herold M
JACC Cardiovasc Imaging; 2014 Feb; 7(2):166-8. PubMed ID: 24524743
[No Abstract] [Full Text] [Related]
3. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
4. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
[TBL] [Abstract][Full Text] [Related]
5. Current role of imaging techniques in cardiac amyloidosis.
Pudis M; Bastarrika Alemañ G
Med Clin (Barc); 2023 Feb; 160(3):121-128. PubMed ID: 36543710
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis.
Xin Y; Hu W; Chen X; Hu J; Sun Y; Zhao Y
Hellenic J Cardiol; 2019; 60(6):375-383. PubMed ID: 30742933
[TBL] [Abstract][Full Text] [Related]
7. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
8. Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution.
Tateishi Y; Yamada Y; Katsuki M; Nagata T; Yamamoto H; Kohashi K; Koga Y; Hashisako M; Kiyozawa D; Mori T; Kuboyama Y; Kakinokizono A; Miyazaki Y; Yamaguchi A; Tsutsui H; Ninomiya T; Naiki H; Oda Y
Pathol Res Pract; 2021 Nov; 227():153635. PubMed ID: 34653913
[TBL] [Abstract][Full Text] [Related]
9. Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
Ablasser K; Verheyen N; Glantschnig T; Agnetti G; Rainer PP
Curr Med Chem; 2019; 26(16):2865-2878. PubMed ID: 29303069
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
11. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
12. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
13. How to Image Cardiac Amyloidosis: A Practical Approach.
Dorbala S; Cuddy S; Falk RH
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis.
Goldstein DS
JACC Cardiovasc Imaging; 2016 Dec; 9(12):1442-1445. PubMed ID: 27838301
[No Abstract] [Full Text] [Related]
15. Transthyretin Cardiac Amyloidosis Disguised as Light Chain Amyloidosis or Multiple Myeloma?
Stein AP; Matthia EL; Petty SA; Stewart B; Vilaro JR; Al-Ani MAZ; Ahmed MM; Aranda JM; Hiemenz JW; Parker AM
Am J Cardiol; 2024 Jan; 210():85-92. PubMed ID: 37852567
[TBL] [Abstract][Full Text] [Related]
16. Potential Cardiac Amyloid PET/CT Imaging Targets for Differentiating Immunoglobulin Light Chain From Transthyretin Amyloidosis.
Schindler TH; Sharma M; Valenta I; Imperiale A; Dilsizian V
Curr Cardiol Rep; 2021 Jun; 23(7):76. PubMed ID: 34081210
[TBL] [Abstract][Full Text] [Related]
17. Early identification of transthyretin-related hereditary cardiac amyloidosis.
Arbustini E; Merlini G
JACC Cardiovasc Imaging; 2014 May; 7(5):511-4. PubMed ID: 24831211
[No Abstract] [Full Text] [Related]
18. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
[TBL] [Abstract][Full Text] [Related]
19. Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis.
Sperry BW; Jones BM; Vranian MN; Hanna M; Jaber WA
JACC Cardiovasc Imaging; 2016 Jul; 9(7):904-906. PubMed ID: 27085437
[No Abstract] [Full Text] [Related]
20. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
